RESULTS OF A COMPARATIVE STUDY OF SARS‐CoV‐2 IgG TESTs

Parallel testing of ninety‐two plasma samples of COVID‐19 convalescent donors, detected positive for IgG in the Abbott Architect SARS‐CoV‐2 IgG test, has shown the coincidence of the testing results with the DIA®‐SARS‐CoV‐2‐NP‐IgG assay, manufactured by DiaProph‐Med.

Parallel testing result showed 100% coincidence (confidential interval was 96% ‐100%) of the two compared assays.

comparative study abbot DPM_01_09_2020
.p
Download P • 185KB

0 views0 comments